Dr Tyler John Heiman, PHARMD | |
105 E Pearl Street, Dighton, KS 67839 | |
(620) 397-5778 | |
(620) 397-2990 |
Full Name | Dr Tyler John Heiman |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 105 E Pearl Street, Dighton, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1750869467 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 1-103095 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Tyler John Heiman, PHARMD 102 Albert Ave, Scott City, KS 67871-6122 Ph: (620) 872-2146 | Dr Tyler John Heiman, PHARMD 105 E Pearl Street, Dighton, KS 67839 Ph: (620) 397-5778 |
News Archive
University of Bath scientists have been awarded a research grant of £1.3 million to develop a portable device to detect the street drug ‘spice' on the spot. They expect the new technology to be ready for use in clinical settings, prisons and across police services within three years.
Specialist Library for Ethnicity & Health, designed to provide health professionals with the latest research and information on ethnic minority health, has announced two successes - in the last year it has doubled the number of research articles it provides, and now the NHS is backing it with a new contract to 2011.
Syngene, a world-leading manufacturer of image analysis solutions, is pleased to introduce a new Dynamic Fielding feature in its GeneSys image capture software.
The new combination agent TAS-102 is able to improve overall survival compared to placebo in patients whose metastatic colorectal cancer is refractory to standard therapies, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona.
Researchers for the first time have induced robust regeneration of nerve tissue connections in injured adult spinal cord sites that control voluntary movement. These findings provide hope that it may be possible to design therapies for paralysis and other impairments of motor function arising from spinal cord injury.
› Verified 3 days ago